2m 2m 2m 2m 2m 2m 2m
SILEXION THERAP (SLXN)
NASDAQ
$1.79-$0.09 (-4.57%)
Price as of Aug 03, 2026 8:30 AM EDT- N/AMarket Cap
- -97.97%1-Year Change
- BiotechnologyIndustry
SILEXION THERAP (SLXN)
$1.79-$0.09 (-4.57%)
SLXN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.88 | ||
Change | +$0.04 (+2.17%) | ||
Open | $1.79 | ||
High | $2.01 | ||
Low | $1.76 | ||
Previous Close | $1.84 | ||
Volume | 92,150 | ||
30-Day Average Volume | 72,851 | ||
1-Week Change | -17.18% | ||
1-Month Change | -26.27% | ||
1-Year Change | -97.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $4.6M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | $32,000.00 | ||
Net Income | -$2.7M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$2.7M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $5,000.00 | ||
EPS | $8.50 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 27 | ||
P/E | 0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 05/29/2026 | ||
Earnings & Revenue